Literature DB >> 9052887

Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.

Y Shigematsu1, M Hamada, H Okayama, Y Hara, Y Hayashi, K Kodama, K Kohara, K Hiwada.   

Abstract

To elucidate whether there is a difference in the progression of target-organ damage between primary aldosteronism and essential hypertension, we compared left ventricular hypertrophy and extracardiac target-organ damage in 23 patients with primary aldosteronism and 116 patients with essential hypertension. The severity of hypertensive retinopathy and the renal involvement in primary aldosteronism were subclinical and similar to those in essential hypertension without left ventricular hypertrophy but significantly milder than those in essential hypertension with left ventricular hypertrophy. There was a strongly significant correlation between the degree of left ventricular mass index and the severity of hypertensive retinopathy and renal involvement independent of office blood pressure in essential hypertension. In contrast, left ventricular hypertrophy markedly progressed despite the mild extracardiac target-organ damage in primary aldosteronism. Left ventricular end-diastolic dimension index in primary aldosteronism (3.16+/-0.50 cm/m2) was significantly larger than in essential hypertension without (2.87+/-0.23) and with (2.88+/-0.22) left ventricular hypertrophy. On the other hand, there was no difference in extracardiac target-organ damage between 13 primary aldosteronism patients with eccentric left ventricular hypertrophy and the 26 essential hypertensive patients with eccentric left ventricular hypertrophy. The results suggest that predominantly volume load, be it due to aldosteronism or other mechanisms, resulting in eccentric left ventricular hypertrophy is less likely to cause extracardiac target-organ damage than hemodynamic or nonhemodynamic mechanisms resulting in concentric left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052887     DOI: 10.1161/01.hyp.29.3.723

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

2.  Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.

Authors:  Victor H Urbieta-Caceres; Xiang-Yang Zhu; Kyra L Jordan; Hui Tang; Kyle Textor; Amir Lerman; Lilach O Lerman
Journal:  Atherosclerosis       Date:  2011-10-12       Impact factor: 5.162

3.  A maximum likelihood approach to electronic health record phenotyping using positive and unlabeled patients.

Authors:  Lingjiao Zhang; Xiruo Ding; Yanyuan Ma; Naveen Muthu; Imran Ajmal; Jason H Moore; Daniel S Herman; Jinbo Chen
Journal:  J Am Med Inform Assoc       Date:  2020-01-01       Impact factor: 4.497

4.  Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.

Authors:  Qihong Wu; Mona Hong; Jianzhong Xu; Xiaofeng Tang; Limin Zhu; Pingjin Gao; Jiguang Wang
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633

Review 5.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

Review 6.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 7.  Aldosterone receptor antagonists: biology and novel therapeutical applications.

Authors:  P Magni; M Motta
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

8.  NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism.

Authors:  Francesca Pizzolo; Francesco Zorzi; Laura Chiecchi; Letizia Consoli; Irene Aprili; Patrizia Guarini; Annalisa Castagna; Gian Luca Salvagno; Chiara Pavan; Oliviero Olivieri
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

Review 9.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

10.  Impact of aldosterone-producing adenoma on cardiac structures in echocardiography.

Authors:  Takayuki Hidaka; Tsuguka Shiwa; Yuichi Fujii; Kenji Nishioka; Hiroto Utsunomiya; Ken Ishibashi; Naoya Mitsuba; Yoshihiro Dohi; Noboru Oda; Kensuke Noma; Satoru Kurisu; Yukiko Nakano; Hideya Yamamoto; Takafumi Iishida; Yukihito Higashi; Yasuki Kihara
Journal:  J Echocardiogr       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.